Charles River Laboratories Price to Free Cash Flow Ratio 2010-2025 | CRL

Historical price to free cash flow ratio values for Charles River Laboratories (CRL) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Charles River Laboratories Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2025-05-19 141.38 12.52
2025-03-31 150.52 $11.29 13.33
2024-12-31 184.60 $9.72 19.00
2024-09-30 196.97 $10.89 18.09
2024-06-30 206.58 $9.43 21.90
2024-03-31 270.95 $8.03 33.74
2023-12-31 236.40 $7.10 33.29
2023-09-30 195.98 $7.16 27.39
2023-06-30 210.25 $5.63 37.31
2023-03-31 201.82 $5.37 37.61
2022-12-31 217.90 $5.75 37.90
2022-09-30 196.80 $5.47 36.00
2022-06-30 213.97 $6.58 32.54
2022-03-31 283.97 $7.99 35.53
2021-12-31 376.78 $10.35 36.42
2021-09-30 412.67 $8.80 46.90
2021-06-30 369.92 $9.46 39.11
2021-03-31 289.83 $9.43 30.72
2020-12-31 249.86 $7.51 33.28
2020-09-30 226.45 $8.85 25.58
2020-06-30 174.35 $8.33 20.93
2020-03-31 126.21 $7.75 16.29
2019-12-31 152.76 $6.85 22.30
2019-09-30 132.37 $5.98 22.13
2019-06-30 141.90 $5.46 25.98
2019-03-31 145.25 $5.44 26.69
2018-12-31 113.18 $6.14 18.43
2018-09-30 134.54 $6.62 20.32
2018-06-30 112.26 $5.49 20.46
2018-03-31 106.74 $5.14 20.77
2017-12-31 109.45 $4.85 22.56
2017-09-30 108.02 $4.84 22.34
2017-06-30 101.15 $5.36 18.86
2017-03-31 89.95 $5.04 17.85
2016-12-31 76.19 $5.46 13.97
2016-09-30 83.34 $5.43 15.35
2016-06-30 82.44 $5.79 14.24
2016-03-31 75.94 $5.89 12.89
2015-12-31 80.39 $5.11 15.72
2015-09-30 63.52 $4.69 13.55
2015-06-30 70.34 $4.28 16.44
2015-03-31 79.29 $3.76 21.10
2014-12-31 63.64 $4.10 15.50
2014-09-30 59.74 $3.61 16.54
2014-06-30 53.52 $3.58 14.95
2014-03-31 60.34 $3.38 17.87
2013-12-31 53.04 $3.50 15.14
2013-09-30 46.26 $3.53 13.09
2013-06-30 41.03 $3.38 12.14
2013-03-31 44.27 $3.57 12.39
2012-12-31 37.47 $3.32 11.30
2012-09-30 39.60 $3.12 12.71
2012-06-30 32.76 $2.88 11.39
2012-03-31 36.09 $3.03 11.89
2011-12-31 27.33 $3.07 8.89
2011-09-30 28.62 $3.06 9.34
2011-06-30 40.65 $2.42 16.82
2011-03-31 38.38 $1.99 19.30
2010-12-31 35.54 $2.00 17.73
2010-09-30 33.15 $1.85 17.95
2010-06-30 34.21 $2.12 16.15
2010-03-31 39.31 $2.16 18.18
2009-12-31 33.69 $2.07 16.29
Sector Industry Market Cap Revenue
Medical Medical Services $6.944B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $140.565B 26.36
Elevance Health (ELV) United States $91.235B 11.77
CVS Health (CVS) United States $79.418B 9.87
Cencora (COR) United States $56.719B 19.73
DiDi Global (DIDIY) China $21.932B 33.29
Natera (NTRA) United States $20.928B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $13.109B 13.88
EUROFINS SCIENT (ERFSF) Luxembourg $11.943B 0.00
CochLear (CHEOY) Australia $11.734B 0.00
Revvity (RVTY) United States $11.115B 19.13
ICON (ICLR) Ireland $10.559B 9.82
Viatris (VTRS) United States $10.281B 3.53
Doximity (DOCS) United States $10.038B 46.76
Avantor (AVTR) United States $9.104B 13.23
Medpace Holdings (MEDP) United States $8.794B 23.36
HealthEquity (HQY) United States $8.442B 41.53
Sonic Healthcare (SKHHY) Australia $8.311B 0.00
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.201B 38.89
Bausch + Lomb (BLCO) Canada $4.160B 24.52
Sotera Health (SHC) United States $3.616B 20.55
Alignment Healthcare (ALHC) United States $3.213B 0.00
Surgery Partners (SGRY) United States $3.025B 39.33
Concentras Parent (CON) United States $2.892B 16.71
Organon (OGN) United States $2.340B 2.49
Ardent Health Partners (ARDT) United States $2.167B 9.24
GeneDx Holdings (WGS) United States $2.026B 78.04
Premier (PINC) United States $1.903B 14.44
Progyny (PGNY) United States $1.843B 40.57
PACS (PACS) United States $1.623B 0.00
GoodRx Holdings (GDRX) United States $1.411B 28.21
Teladoc Health (TDOC) United States $1.282B 0.00
Pediatrix Medical (MD) United States $1.277B 9.72
Establishment Labs Holdings (ESTA) $1.065B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.986B 15.39
Nutex Health (NUTX) United States $0.981B 14.82
Agilon Health (AGL) United States $0.969B 0.00
AMN Healthcare Services Inc (AMN) United States $0.858B 8.04
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.679B 4.57
InnovAge Holding (INNV) United States $0.566B 0.00
Enhabit (EHAB) United States $0.539B 44.38
Auna S.A (AUNA) Luxembourg $0.524B 13.88
Sonida Senior Living (SNDA) United States $0.494B 0.00
LifeMD (LFMD) United States $0.481B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.404B 0.00
SBC Medicals (SBC) United States $0.353B 0.00
Oncology Institute (TOI) United States $0.231B 0.00
Performant Healthcare (PHLT) United States $0.211B 0.00
Beauty Health (SKIN) United States $0.205B 0.00
DocGo (DCGO) United States $0.148B 24.17
Sera Prognostics (SERA) United States $0.087B 0.00
So-Young (SY) China $0.087B 0.00
KindlyMD (KDLY) United States $0.084B 0.00
OncoCyte (OCX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Biodesix (BDSX) United States $0.044B 0.00
Basel Medical Group (BMGL) Singapore $0.039B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.033B 0.00
Pheton Holdings (PTHL) China $0.032B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
ModivCare (MODV) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00